当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Anti-Cancer Drugs杂志
Anti-Cancer Drugs
基本信息
期刊名称 Anti-Cancer Drugs
ANTI-CANCER DRUG
期刊ISSN 0959-4973
期刊官方网站 https://journals.lww.com/anti-cancerdrugs/pages/default.aspx
是否OA No
出版商 Lippincott Williams and Wilkins Ltd.
出版周期 Monthly
文章处理费 登录后查看
始发年份 1990
年文章数 142
影响因子 1.8(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 ONCOLOGY 肿瘤学4区
PHARMACOLOGY & PHARMACY 药学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.8 0.476 0.360
Medicine
Pharmacology (medical)
129/272 52%
Medicine
Oncology
218/404 46%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
181/313 42%
Biochemistry, Genetics and Molecular Biology
Cancer Research
161/230 30%
补充信息
自引率 2.40%
H-index 88
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0959-4973%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/ACD
收稿范围
Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug